Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Implementing an Automated DOE in Twin Screw Wet Granulation
Sustainable Pharmaceutical Packaging
Pre-filled Syringe Packaging Trends
Liquid Pharmaceutical Filling: Small, Smaller, Micro Batches
Newsmakers Q&A: BioVectra
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Parexel Announces CEO Transition
DifGen Acquires FDA-Registered Manufacturing Facility
Quotient Sciences Makes Executive Leadership Team Appointments
Plenaries Discuss AI and Next-Gen Modality Development at AAPS NBC
SCHOTT Pharma Invests $371M in U.S. Prefillable Syringe Mfg. Facility
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
DifGen Acquires FDA-Registered Manufacturing Facility
Samsung Life Science Fund Invests in BrickBio
Assurance of Global Pharma Supply
Upgraded Syngene Biologics Facility to Be Operational in Second Half of 2024
GeminiBio Introduces Aseptic Assurance System
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
SCHOTT Pharma Invests $371M in U.S. Prefillable Syringe Mfg. Facility
Assurance of Global Pharma Supply
Sustainable Pharmaceutical Packaging
Pre-filled Syringe Packaging Trends
Liquid Pharmaceutical Filling: Small, Smaller, Micro Batches
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Parexel Announces CEO Transition
Samsung Life Science Fund Invests in BrickBio
Selvita Adds Antibody Discovery and Development Capabilities
The High Five: Key Regulatory Topics for Drug Development in 2024
Pace Life Sciences Acquires New Jersey Lab
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
The High Five: Key Regulatory Topics for Drug Development in 2024
The “Hows” of Drug Shortages
SGS Lab in Fairfield, NJ Earns ISO/IEC 17025:2017 Certification
The Road Ahead for CDMOs in 2024
Never Assume!
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
Lannett CDMO
SUANFARMA CDMO
CMC Pharmaceuticals
Abzena
Vetter Pharma International
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
Lannett CDMO
SUANFARMA CDMO
CMC Pharmaceuticals
Abzena
Vetter Pharma International
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 25 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Cytotoxics and High Potency Manufacturing
All
APIs
Aseptic Processing
cGMP Manufacture
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/Technology Transfer
Solid Dosage/Creams/Ointments
Capsules
|
Cytotoxics and High Potency Manufacturing
|
Solid Dosage/Creams/Ointments
|
Solid Dosage/Semi-solids
Multi-particulate Formulations – Tablets or Capsules?
Multiple-unit dosage forms are gaining significant popularity among drug developers due to their benefits.
Subhashis Chakraborty and Ananya Sen, ACG
03.11.24
Cytotoxics and High Potency Manufacturing
|
Drug Development
Trends in the Development of ADCs
Targeting tumor heterogeneity with antibody-drug conjugates and novel payloads.
Louise Duffy, Chief Technical Officer, Abzena
02.01.24
Cytotoxics and High Potency Manufacturing
|
Drug Development
|
Process Development
HPAPI Trends: Drug Synthesis in Early Development
Addressing the challenge of new clinical targets and highly potent compounds.
Rob Abbenhuis, Chemistry Division Manager, Ardena
02.01.24
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
|
Drug Development
|
Fill/Finish
|
Information Technology
Calling All Laureates in Oncology Drug Manufacturing
Leveraging technology to reduce development timelines while maintaining safety will be key to delivering critical oncology products.
Rebecca Coutts, General Manager, PCI Pharma Services
02.01.24
APIs
|
Breaking News
|
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
Olon Group to Add New High Potency API Suite in Ohio
Expands its capabilities to serve clients developing innovative therapies for cancer, rare diseases and other challenging therapeutic areas.
01.29.24
APIs
|
Cytotoxics and High Potency Manufacturing
Trends in the Development of ADCs
Targeting tumor heterogeneity with antibody-drug conjugates and novel payloads.
Louise Duffy, Chief Technical Officer, Abzena
01.25.24
APIs
|
Cytotoxics and High Potency Manufacturing
API Market Trends
Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer.
Online Exclusives
Grand View Research
01.25.24
Breaking News
|
Cytotoxics and High Potency Manufacturing
|
Drug Development
|
Drug Discovery
|
Industry News
Experic Installs New Capsule Filling Machine at New Jersey Facility
Provides enhanced protection of employees and the environment from highly potent pharmaceutical products.
12.07.23
Cytotoxics and High Potency Manufacturing
Developing HPAPIs: Leveraging Classification Systems to Mitigate Risk
Exploring the importance of robust classification systems to accurately characterize and classify HPAPIs for safe handling.
Catherine Wilkes, Executive Director of Environmental, Health & Safety, Quotient Sciences
11.14.23
Cytotoxics and High Potency Manufacturing
ABCs of ADCs: A Brief Primer
Reviewing some pros and cons that exist within the outsourcing realm for antibody drug conjugates.
Ben Locwin , Contributing Editor
11.14.23
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
The Evolution of HPAPI Manufacturing for CDMOs
The demand for highly potent APIs has been steadily increasing, driven by the development of targeted therapies in oncology and other disease areas.
Adam Kujath, EVP and Site Head, Germantown, Sterling Pharma Solutions
10.12.23
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
"3 Key Trends" with Srinivasan Shanmugam
Adare Pharma Solutions’ Senior Director of Pharmaceutical Sciences, Business Support, and New Technologies offers his thought leadership.
Online Exclusives
Contract Pharma
09.28.23
Cytotoxics and High Potency Manufacturing
|
Facilities
HPAPI Manufacturing Trends
Oncology drugs, advancements in manufacturing technology, and a rise in capacity to meet greater demand drive market growth.
Tim Wright, Editor, Contract Pharma
09.13.23
Cytotoxics and High Potency Manufacturing
|
Drug Development
"3 Key Trends" with Louise Duffy
Abzena’s Chief Technical Officer offers her thought leadership.
Online Exclusives
Contract Pharma
08.04.23
Analytical Services
|
APIs
|
Bioanalytical Services
|
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
|
Drug Development
|
Laboratory Testing
Talking Toxicology for Safer HPAPIs
Toxicological evaluation is important at every stage of HPAPI development and manufacturing—CDMOs help ensure new treatments are brought to market safely.
Sponsored
released by
Evonik
07.20.23
Breaking News
|
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
|
Industry News
WuXi STA Debuts First HP Sterile Injectable Mfg. Line at Wuxi Site
Annual capacity of 12 million units enhances manufacturing capabilities and capacity for injectable dosage forms.
07.18.23
Breaking News
|
Clinical Trial Materials
|
Cytotoxics and High Potency Manufacturing
|
Drug Development
|
Industry News
NorthStar Medical Radioisotopes Executes Supply Agreement with Bayer
NorthStar’s non-carrier added Ac-225 to be used in Bayer’s radiopharmaceutical programs.
07.18.23
APIs
|
Breaking News
|
Cytotoxics and High Potency Manufacturing
|
Facilities
|
Industry News
Aenova Opens New Building for Highly Potent Drugs
Makes total investment of around €25 million at the Regensburg site to increase development and production capacities.
06.23.23
APIs
|
Breaking News
|
Cytotoxics and High Potency Manufacturing
|
Drug Development
|
Drug Discovery
|
Facilities
|
Industry News
OLON Enters ADC Market
Invests €22 million in a new facility dedicated to ultra-potent compounds.
05.30.23
APIs
|
Breaking News
|
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
|
Drug Development
|
Industry News
AmbioPharm Expands South Carolina Headquarters
Includes increasing synthesis capacity and supporting growth in late phase and commercial production.
05.18.23
Breaking News
Parexel Announces CEO Transition
DifGen Acquires FDA-Registered Manufacturing Facility
Quotient Sciences Makes Executive Leadership Team Appointments
Plenaries Discuss AI and Next-Gen Modality Development at AAPS NBC
SCHOTT Pharma Invests $371M in U.S. Prefillable Syringe Mfg. Facility
View Breaking News >
CURRENT ISSUE
March 2024
Implementing an Automated DOE in Twin Screw Wet Granulation
Sustainable Pharmaceutical Packaging
Pre-filled Syringe Packaging Trends
Liquid Pharmaceutical Filling: Small, Smaller, Micro Batches
Newsmakers Q&A: BioVectra
Multi-particulate Formulations – Tablets or Capsules?
Manufacturing Equipment Trends
OSD Outsourcing: Savvy CMOs Hone Skills as Complex APIs Fuel Demand
Catalent Acquisition by Novo Holdings: Evolution of the Industry(?)
The Road Ahead for CDMOs in 2024
View More >